The Ahmed Versus Baerveldt Study: Three-Year Treatment Outcomes – Corrected Proof

Objective: To compare 2 commonly used aqueous drainage devices for the treatment of refractory glaucoma.Design: International, multicenter, randomized trial.Participants: Patients aged 18 years or older with uncontrolled or high-risk glaucoma refractory to maximum medical therapy, many of whom had failed trabeculoplasty and trabeculectomy.Methods: Eligible patients were randomized to an Ahmed-FP7 valve implant (New World Medical, Inc., Rancho Cucamonga, CA) or a Baerveldt-350 implant (Abbott Medical Optics, Inc., Santa Ana, CA) using a standardized surgical technique.Main Outcome Measures: The primary outcome was failure, defined as intraocular pressure (IOP) outside of the target range (5–18 mmHg, with ≥20% reduction from baseline) for (Read more...)

Full Story →